缺血性卒中血管内治疗后不完全再灌注的自然演变
该系统综述与Meta分析纳入6项研究共950例患者,评估血管内治疗后不完全再灌注(eTICI<3)的自然演变。结果显示41%(四分位距33%-51%)的患者在术后24小时出现延迟再灌注,且延迟再灌注与90天功能独立可能性更高相关(OR 2.5,95%CI 1.9-3.4)。
要点
- 不完全再灌注(eTICI<3)患者中约41%在术后24小时出现延迟再灌注。
- 延迟再灌注与90天功能独立(mRS 0-2)可能性更高相关(OR 2.5,95%CI 1.9-3.4)。
- 作者认为该亚组从追加再灌注策略中获益有限或可能有害。
核心结论
- 近半数eTICI<3患者出现延迟再灌注,并带来有利的临床结局。
- 该亚组从追加再灌注策略(如动脉内溶栓或二次取栓)中可能获益有限或潜在有害。
- 准确预测不完全再灌注的演变可优化干预结束时辅助再灌注策略的患者选择。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、Embase和PubMed截至2024年3月1日。
- 仅纳入全文英文文章,报告不完全再灌注组织有利演变(延迟再灌注或无新发梗死)或不利进展(持续灌注缺损或新发梗死)的发生率。
- 共纳入6项研究,涉及950例患者(女性50.7%;中位年龄71岁,四分位距60-79)。
- 4项研究通过磁共振灌注成像评估不完全再灌注的演变,2项研究使用弥散加权成像和非增强计算机断层扫描成像,以新发梗死表示不利进展。
- 5项研究将不完全再灌注定义为eTICI 2b50或2c。
主要发现
- 延迟再灌注在术后24小时发生于41%(四分位距33%-51%)的病例。
- 实现延迟再灌注与90天功能独立可能性更高相关(OR 2.5,95%CI 1.9-3.4)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A third of endovascularly treated patients with stroke experience incomplete reperfusion (expanded Thrombolysis in Cerebral Infarction [eTICI] <3), and the natural evolution of this incomplete reperfusion remains unknown. We systematically reviewed the literature and performed a meta-analysis on the natural evolution of incomplete reperfusion after endovascular therapy. METHODS: A systematic review of MEDLINE, Embase, and PubMed up until March 1, 2024, using a predefined strategy. Only full-text English-written articles reporting rates of either favorable (ie, delayed reperfusion (DR) or no new infarct) or unfavorable progression (ie, persistent perfusion deficit or new infarct) of incompletely reperfused tissue were included. The primary outcome was the rate of DR and its association with functional independence (modified Rankin Scale score, 0-2) at 90 days postintervention. Pooled odds ratios with 95% CIs were calculated using a random-effects model. RESULTS: Six studies involving 950 patients (50.7% female; median age, 71 years; interquartile range, 60-79) were included. Four studies assessed the evolution of incomplete reperfusion on magnetic resonance imaging perfusion imaging, while 2 studies used diffusion-weighted imaging and noncontrast computed tomography imaging, where new infarct was used to denote unfavorable progression. Five studies defined incomplete reperfusion as eTICI 2b50 or 2c. DR occurred in 41% (interquartile range, 33%-51%) of cases 24 hours postintervention. Achieving DR was associated with a higher likelihood of functional independence at 90 days (odds ratio, 2.5 [95% CI, 1.9-3.4]). CONCLUSIONS: Nearly half of eTICI <3 patients achieve DR, leading to favorable clinical outcomes. This subgroup may derive limited or potentially harmful effects from pursuing additional reperfusion strategies (eg, intra-arterial lytics or secondary thrombectomy). Accurately predicting the evolution of incomplete reperfusion could optimize patient selection for adjunctive reperfusion strategies at the end of an intervention. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifiers: NCT05499832.
引用
- Mujanovic A, Windecker D, Cimflova P, et al. Natural Evolution of Incomplete Reperfusion in Patients Following Endovascular Therapy After Ischemic Stroke. Stroke. 2024. PMID: 39567366. doi:10.1161/STROKEAHA.124.049641
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。